-
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc. DC CAFC
- 1:15-cv-00078
- D. Del.
- Judge: Richard G. Andrews
- Filed: 01/23/2015
- Closed: 05/01/2019
- Latest Docket Entry: 05/02/2019
- PACER
- Docket updated daily
2
Plaintiffs
1
Defendant
1
Accused
Product
3
Patents-in-Suit
1,560
Days in
Litigation
-
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc. DC CAFC
- 1:15-cv-00078
- D. Del.
- Judge: Richard G. Andrews
- Filed: 01/23/2015
- Closed: 05/01/2019
- Latest Docket Entry: 05/02/2019
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
-
Infringement
Par Pharmaceutical, Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
2.5 mg, 5 mg, 7.5 mg, 10 mg everolimus oral tablets | US 5,665,772 A |
10
|
Infringement
Entry 128
|